Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by ZigZagon Mar 01, 2018 12:51am
162 Views
Post# 27641703

We just need new contracts...

We just need new contracts...The contract with Mexico give a revenue of 16.44$ per scan (5.26mil $ / 320000 scans).  To be profitable, Diagnos need yearly arround 6 mil$ to cover its costs and to have few hundred thousands of dollars to have the money to start new contracts without to have to do new financing... All extra scan from the 400001th will send us to the profitable side.   With all what  i read here in this bullbord, i quite sure that we won't have to wait until 2019 before to get new contracts.  And also, the cardio will probably give a boost to these revenues by the end of the year. You also have to think that most of patients scanned for Retinopathy before the launch of Cardio will be eligible to be diagnose for cardio without to have to be scanned again.  As the patients with diabete usually are over 40 years old, they will probably be massivelly diagnosed for the cardio. Imagine to get the order form mexico to diagnose for cardio 200000 patients sanned since a year for retinopathy. May be for half the price of the 16,44$ recieved earlier as we don't have to pay anyone to take a new picture. It can give a revenu of  1,644,000$ with may be few days of processing by computers. A rain of dollars....  and more if there is new pathologies to be diagnosed in the futur,,..   i stay optimist and patient since 2014...

Bullboard Posts